Seno Biotech Introduces Low-Sodium Albumin Peptide at Boao Health Expo
Seno Biotech’s low-sodium albumin peptide highlights egg protein innovation for clean-label, high-protein nutrition and health food formulation.

Wang Yu
Director of Research and Development

The Boao Health Food Science Conference and Expo brought together health food enterprises, ingredient suppliers and nutrition experts to discuss evidence-based innovation, international cooperation and new product development. Seno Biotech presented its low-sodium albumin peptide as an egg-derived protein ingredient designed for clean-label, high-protein nutrition applications.
Low-Sodium Albumin Peptide for Clean-Label Nutrition
Developed through biotechnology and process optimization, the albumin peptide reduces sodium content while preserving the nutritional value and bioactivity of egg protein peptides. The ingredient responds to growing formulation demand for low-sodium nutrition, sports nutrition, healthy aging products and special dietary foods.
Seno Biotech’s R&D team introduced the product’s development pathway, technical advantages and application potential to industry visitors. The launch highlights the company’s focus on traceable egg-derived bioactive ingredients and practical formulation support for health food brands.
Technical Development and Market Applications
The low-sodium albumin peptide strengthens Seno Biotech’s egg protein ingredient portfolio and supports broader market adoption of clean-label, science-based nutrition solutions.


